KR101947352B1 - 인지 건강 및 기능을 향상시키는 식물 추출물 - Google Patents
인지 건강 및 기능을 향상시키는 식물 추출물 Download PDFInfo
- Publication number
- KR101947352B1 KR101947352B1 KR1020157006128A KR20157006128A KR101947352B1 KR 101947352 B1 KR101947352 B1 KR 101947352B1 KR 1020157006128 A KR1020157006128 A KR 1020157006128A KR 20157006128 A KR20157006128 A KR 20157006128A KR 101947352 B1 KR101947352 B1 KR 101947352B1
- Authority
- KR
- South Korea
- Prior art keywords
- memory
- cognitive
- composition
- learning
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261681414P | 2012-08-09 | 2012-08-09 | |
| US61/681,414 | 2012-08-09 | ||
| PCT/US2013/054274 WO2014026081A1 (en) | 2012-08-09 | 2013-08-09 | Plant extracts for improving cognitive health and function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20150041654A KR20150041654A (ko) | 2015-04-16 |
| KR101947352B1 true KR101947352B1 (ko) | 2019-02-12 |
Family
ID=50066333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020157006128A Active KR101947352B1 (ko) | 2012-08-09 | 2013-08-09 | 인지 건강 및 기능을 향상시키는 식물 추출물 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140044813A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2882443B1 (cg-RX-API-DMAC7.html) |
| JP (4) | JP2015524484A (cg-RX-API-DMAC7.html) |
| KR (1) | KR101947352B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN111358832A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013299491B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015002739A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2880708C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2715005T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2882443T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014026081A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200134170A (ko) * | 2019-05-21 | 2020-12-01 | 건국대학교 글로컬산학협력단 | 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140044813A1 (en) * | 2012-08-09 | 2014-02-13 | Kemin Industries, Inc. | Plant Extracts for Improving Cognitive Health and Function |
| KR20160113277A (ko) * | 2014-01-30 | 2016-09-28 | 케민 인더스트리즈, 인코포레이티드 | 인지 기능을 개선시키기 위한 식물 추출물 |
| CA2961378A1 (en) * | 2014-09-15 | 2016-03-24 | Kemin Industries, Inc. | Plant extracts for improving cognitive function |
| CA2963817A1 (en) * | 2014-10-08 | 2016-04-14 | Abbott Laboratories | Nutritional compositions comprising an oxidizable component and water-soluble plant extract |
| JP2020508962A (ja) * | 2016-11-11 | 2020-03-26 | ケミン、インダストリーズ、インコーポレーテッドKemin Industries, Inc. | 神経新生の促進を通して脳の健康を改善するための植物抽出物の使用 |
| CN106727915B (zh) * | 2017-01-18 | 2020-03-31 | 云南德彩堂生物医药科技有限公司 | 一种稳定高效提高记忆的组合物及其制备方法和应用 |
| BR112020008727A2 (pt) * | 2017-10-30 | 2020-10-20 | Neuropore Therapies, Inc. | fenil sulfonil fenil triazol tionas substituídas e usos destas |
| CN109602759B (zh) * | 2019-01-17 | 2020-10-09 | 广西医科大学 | 罗汉松实多糖的用途 |
| CN110463846A (zh) * | 2019-07-30 | 2019-11-19 | 河南科技学院 | 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用 |
| JP7330630B2 (ja) * | 2019-11-20 | 2023-08-22 | 株式会社ニップン | ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物 |
| JP2022104122A (ja) * | 2020-12-28 | 2022-07-08 | 株式会社ニップン | オキシトシン関連シグナル活性化剤 |
| US20240139272A1 (en) * | 2022-10-27 | 2024-05-02 | Kemin Industries, Inc. | Use of a spearmint extract for retina neurotrophism |
| JP2024122605A (ja) * | 2023-02-28 | 2024-09-09 | 株式会社ニップン | オリゴデンドロサイト分化促進剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1219509C (zh) * | 1998-05-16 | 2005-09-21 | 财团法人牧岩生命工学研究所 | 迷迭香酸及其衍生物用于制备免疫抑制剂药物的用途 |
| JP4629822B2 (ja) * | 1999-12-02 | 2011-02-09 | 長瀬産業株式会社 | 神経成長因子合成促進剤 |
| JP2006199666A (ja) * | 2005-01-24 | 2006-08-03 | Nagase & Co Ltd | 健忘症の予防・治療剤 |
| WO2007047978A2 (en) * | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP1930019A1 (en) * | 2006-11-24 | 2008-06-11 | DSMIP Assets B.V. | Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
| EP1925213A1 (en) * | 2006-11-24 | 2008-05-28 | DSMIP Assets B.V. | Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses |
| CA2676353A1 (en) * | 2007-01-24 | 2008-07-31 | University Of Guelph | Production of rosmarinic acid from spearmint and uses thereof |
| US7972633B2 (en) * | 2007-02-07 | 2011-07-05 | Applied Cognitive Sciences, LLC | Nutritional supplements for healthy memory and mental function |
| DK2060192T3 (en) * | 2007-10-17 | 2016-02-22 | Wild Gmbh & Co Kg Rudolf | Composition comprising lemon balm extracts |
| US9950019B2 (en) * | 2009-06-12 | 2018-04-24 | Generex Pharmaceuticals, Inc. | Compositions and methods for the prevention and treatment of brain diseases and conditions |
| CN101773488A (zh) * | 2010-02-10 | 2010-07-14 | 青岛大学 | 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用 |
| JP2011256118A (ja) * | 2010-06-07 | 2011-12-22 | Kao Corp | Il−8及びgm−csf発現抑制剤 |
| US20140044813A1 (en) * | 2012-08-09 | 2014-02-13 | Kemin Industries, Inc. | Plant Extracts for Improving Cognitive Health and Function |
-
2013
- 2013-08-08 US US13/962,609 patent/US20140044813A1/en not_active Abandoned
- 2013-08-09 BR BR112015002739A patent/BR112015002739A2/pt not_active Application Discontinuation
- 2013-08-09 PL PL13828399T patent/PL2882443T3/pl unknown
- 2013-08-09 AU AU2013299491A patent/AU2013299491B2/en active Active
- 2013-08-09 ES ES13828399T patent/ES2715005T3/es active Active
- 2013-08-09 CA CA2880708A patent/CA2880708C/en active Active
- 2013-08-09 WO PCT/US2013/054274 patent/WO2014026081A1/en not_active Ceased
- 2013-08-09 CN CN202010406999.5A patent/CN111358832A/zh active Pending
- 2013-08-09 EP EP13828399.9A patent/EP2882443B1/en active Active
- 2013-08-09 KR KR1020157006128A patent/KR101947352B1/ko active Active
- 2013-08-09 CN CN201380051858.4A patent/CN104684562A/zh active Pending
- 2013-08-09 JP JP2015526726A patent/JP2015524484A/ja active Pending
-
2021
- 2021-01-08 JP JP2021001953A patent/JP2021066735A/ja active Pending
-
2022
- 2022-12-09 JP JP2022196766A patent/JP2023027232A/ja active Pending
-
2024
- 2024-09-17 US US18/887,782 patent/US20250009703A1/en active Pending
- 2024-11-29 JP JP2024208100A patent/JP2025029029A/ja active Pending
Non-Patent Citations (1)
| Title |
|---|
| Behavioural Brain Research 180 (2007) 139-145* |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200134170A (ko) * | 2019-05-21 | 2020-12-01 | 건국대학교 글로컬산학협력단 | 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물 |
| KR102421772B1 (ko) * | 2019-05-21 | 2022-07-18 | 건국대학교 글로컬산학협력단 | 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20140044813A1 (en) | 2014-02-13 |
| EP2882443B1 (en) | 2019-01-16 |
| JP2015524484A (ja) | 2015-08-24 |
| AU2013299491B2 (en) | 2018-03-15 |
| JP2025029029A (ja) | 2025-03-05 |
| JP2021066735A (ja) | 2021-04-30 |
| ES2715005T3 (es) | 2019-05-31 |
| EP2882443A1 (en) | 2015-06-17 |
| CN111358832A (zh) | 2020-07-03 |
| JP2023027232A (ja) | 2023-03-01 |
| KR20150041654A (ko) | 2015-04-16 |
| CA2880708C (en) | 2023-09-26 |
| AU2013299491A1 (en) | 2015-02-12 |
| BR112015002739A2 (pt) | 2017-07-04 |
| US20250009703A1 (en) | 2025-01-09 |
| WO2014026081A1 (en) | 2014-02-13 |
| CN104684562A (zh) | 2015-06-03 |
| PL2882443T3 (pl) | 2019-06-28 |
| EP2882443A4 (en) | 2016-01-06 |
| CA2880708A1 (en) | 2014-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250009703A1 (en) | Plant extracts for improving cognitive health and function | |
| Farr et al. | Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice | |
| Di Domenico et al. | Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants | |
| Jangra et al. | Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus: Jangra et al. | |
| Mizrahi et al. | Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD | |
| Aboul Ezz et al. | The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate | |
| Camilleri et al. | The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease | |
| Samarghandian et al. | Anti-oxidative effects of safranal on immobilization-induced oxidative damage in rat brain | |
| Sharman et al. | Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective? | |
| Lin et al. | Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway | |
| Srivastava et al. | Protective effect of curcumin by modulating BDNF/DARPP32/CREB in arsenic-induced alterations in dopaminergic signaling in rat corpus striatum | |
| Alam et al. | Neuroprotective potential of adenyl cyclase/cAMP/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats | |
| Vassallo et al. | Mediterranean diet and dementia of the Alzheimer type | |
| Cuciniello et al. | Conjugated linoleic acid downregulates Alzheimer's hallmarks in aluminum mouse model through an Nrf2-mediated adaptive response and increases brain glucose transporter levels | |
| Mohamed et al. | Evaluation of anti-Alzheimer activity of Echinacea purpurea extracts in aluminum chloride-induced neurotoxicity in rat model | |
| Moradi Vastegani et al. | Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats | |
| Abu-Taweel et al. | Pomegranate juice rescues developmental, neurobehavioral and biochemical disorders in aluminum chloride-treated male mice | |
| Dibacto et al. | The neuroprotective effect of Xylopia parviflora against aluminum chloride-induced neurotoxicity in rats | |
| Cho et al. | Neuroprotective effects of Actinidia eriantha cv. Bidan kiwifruit on amyloid beta-induced neuronal damages in PC-12 cells and ICR mice | |
| Chatterjee et al. | Exploring pathological targets and advancing pharmacotherapy in autism spectrum disorder: contributions of glial cells and heavy metals | |
| Hu et al. | Protective effect of Huanglianjiedu Decoction on microcystin-LR induced nerve injury | |
| Gu et al. | Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis | |
| Boldrini et al. | Potential use of modulators of oxidative stress as add-on therapy in patients with anxiety disorders | |
| Yan et al. | Dietary beta-hydroxybutyrate is superior to a ketogenic diet to improve behavior and abnormal myelination in a mouse model of NMDA receptor deficiency | |
| Mecocci et al. | Antioxidant agents in Alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20150309 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20180705 Comment text: Request for Examination of Application |
|
| PA0302 | Request for accelerated examination |
Patent event date: 20180705 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20181015 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190107 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190205 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20190207 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20220128 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230126 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240130 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250124 Start annual number: 7 End annual number: 7 |